Accelerating Rare disease Cures (ARC) Program
The mission of CDER ’s ARC Program is to drive scientific and regulatory innovation and engagement to accelerate the availability of treatments for patients with rare diseases.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Drugs & Pharmacology | Rare Diseases